Digest Network Come funziona
Network
/
Società
Se
Non verificato

Sensei Biotherapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute

9 comunicati stampa

Guarda tutti i comunicati
15/06/2026
Mercato del lavoro
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer
Fonte
Sensei Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
04/06/2026
Mercato azionario
Finanza
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Sensei Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
15/05/2026
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Oncologia
Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Fonte
Sensei Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
05/05/2026
Industria
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer
Fonte
Sensei Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
09/04/2026
Web e Social Network
Fiere
Eventi
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Sanità
Medicina - Varie
Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Fonte
Sensei Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
30/03/2026
Mercato azionario
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
Fonte
Sensei Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
17/03/2026
Mercato azionario
Finanza
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Sensei Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
25/02/2026
Mercato azionario
Finanza
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Sensei Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0
18/02/2026
Multimedialità
Industria
Mercato azionario
Web e Social Network
Telefonia e Varie
Scienza
Medicina - Varie
Sanità
Biotecnologia
Farmaceutica
Salute
Oncologia
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
Fonte
Sensei Biotherapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0